Skip to main content
FinSpry Logo
FinSpry
IRD logo
IRD
(NASDAQ)
Opus Genetics, Inc.
$3.72-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Opus Genetics (IRD) Stock Price & Financial Analysis

Opus Genetics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$4.04 - $4.26
52-Week High$5.81
52-Week Low$0.90
Open$4.17
Volume1.06M
Average Volume (3M)894.58K
Market Cap3.22B
Shares Outstanding868.91M
Price to Sales (P/S)269.02
Price to Book (P/B)-70.33
EV/EBITDA-30.02
Revenue (TTM)11.98M
Net Income (TTM)-106.93M
Free Cash Flow (TTM)-38.99M
EPS (TTM)$-0.26
Profit Margin-892.36%
Operating Margin-359.13%
50-Day MA$4.66
200-Day MA$3.20
52-Week Change301.73%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Opus Genetics

What is the current stock price for IRD?

As of the latest trading session, IRD stock trades at $4.07. The 52-week range is $0.90–$5.81, with a day range of $4.04–$4.26.

What is the P/E ratio for IRD?

The P/E ratio (Price-to-Earnings) for IRD is shown in the Key Statistics section. This valuation metric helps compare Opus Genetics, Inc. to industry peers.

Does IRD pay dividends?

Opus Genetics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IRD?

Based on 15 analysts, the consensus for IRD is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IRD?

Opus Genetics's market capitalization is $3.54B, classifying it as a mid-cap company. Opus Genetics operates in the Healthcare sector within the Biotechnology industry.